Latest Industry Insights

Discover how one of the biggest biopharma acquisitions of 2025 aims to expand rare tumor therapies for hard-to-treat cancers like desmoid tumors.

In this article, we explore how AI, robotics and advanced software are transforming biopharma labs, the challenges of adopting these technologies and the vision for the “Lab of the Future.”

In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in nanoparticle drug delivery.

Explore how onshoring pharmaceutical manufacturing could reshape US drug production and boost supply chain resilience.

In this interview, Technology Networks spoke with Gene Mack, chief executive officer and president of Gain Therapeutics, to find out more about the company’s mission, its science and its vision for the future of neuroscience drug development.

In the heart of Cambridge, a quiet revolution is reshaping the way science startups scale: one built not only on breakthrough molecules and patents, but also on collaborative spaces, shared values and pragmatic support.

Are GLP-1 weight loss drugs the best we can do? Learn why some are pursuing alternatives to appetite suppression.

In this interview, Dr. Iain Yisu Wang from MedChemExpress discusses the growing role of AI, the value of phenotypic screening and how tailored compound libraries are helping researchers keep up with the increasing complexity of drug discovery.

AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.

Discover how scalable, human-based in vitro models are reshaping discovery pipelines, balancing complexity with reproducibility, and enabling new kinds of experimentation that go beyond the limits of animal research.